Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2021

Hozzl · 2022-12-31T05:26:48Z

Explore the details of Senate Bill 2146 Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2021 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/31/2022, 5:26 AM

Congressional Summary of S 2146

Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2021

This bill establishes the Task Force on Innovative Diabetes Technologies and Services to address the accessibility of innovative diabetes technologies and services to Medicare beneficiaries. The bill defines innovative diabetes technologies and services as medical technologies and services for diabetes treatment that are not covered under Medicare.

Among other activities, the task force must (1) recommend ways to improve access to innovative diabetes technologies and services through new or alternative payment models and existing policies, and (2) propose changes to foster collaboration between the Food and Drug Administration and the Centers for Medicare & Medicaid Services to streamline approval and coverage.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 2146

Bill S 2146 is currently in the status of Bill Introduced since June 21, 2021. Bill S 2146 was introduced during Congress 117 and was introduced to the Senate on June 21, 2021. Bill S 2146's most recent activity was Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4657) as of June 21, 2021

Bipartisan Support of Bill S 2146

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 2146

Primary Policy Focus

Health

Potential Impact Areas

- Administrative law and regulatory procedures

- Advanced technology and technological innovations

- Advisory bodies

- Congressional oversight

- Department of Health and Human Services

- Digestive and metabolic diseases

- Drug safety, medical device, and laboratory regulation

- Health care coverage and access

- Health technology, devices, supplies

- Medical research

- Medicare

Alternate Title(s) of Bill S 2146

A bill to establish within the Office of the Secretary of Health and Human Services a special task force on ensuring Medicare beneficiary access to innovative diabetes technologies and services.

Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2021